Double doses of clopidogrel better than standard doses for heart patients undergoing angioplasty
Monday, August 31, 2009 - 09:28
in Health & Medicine
Barcelona, Spain, 30 August: A landmark international study led by McMaster University researchers found high doses of the blood thinner clopidogrel (Plavix) significantly reduce complications in heart patients undergoing angioplasty to clear blocked arteries.